(Y44) Agents primarily affecting blood constituents

More details coming soon

Icon
178 229 in individuals diagnosis agents primarily affecting blood constituents confirmed
Icon
15 706 deaths with diagnosis agents primarily affecting blood constituents
Icon
9% mortality rate associated with the disease agents primarily affecting blood constituents

Diagnosis agents primarily affecting blood constituents is diagnosed Women are 11.62% more likely than Men

78 763

Men receive the diagnosis agents primarily affecting blood constituents

8 102 (10.3 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
99 466

Women receive the diagnosis agents primarily affecting blood constituents

7 604 (7.6 %)

Died from this diagnosis.

Risk Group for the Disease agents primarily affecting blood constituents - Men aged 75-79 and Women aged 80-84

Icon
In Men diagnosis is most often set at age 0-5, 15-19, 25-34, 40-94
Icon
Less common in men the disease occurs at Age 0-1, 5-14, 20-24, 35-39, 95+Less common in women the disease occurs at Age 5-29, 40-49, 95+
Icon
In Women diagnosis is most often set at age 0-5, 30-39, 50-94

Disease Features agents primarily affecting blood constituents

Icon
Absence or low individual and public risk
Icon

Agents primarily affecting blood constituents - what does this mean

Agents primarily affecting blood constituents typically cause diseases by altering the number, size, and/or shape of red blood cells, white blood cells, or platelets. these agents can be viruses, bacteria, fungi, or parasites, and can lead to anemia, thrombocytopenia, or leukopenia.

What happens during the disease - agents primarily affecting blood constituents

The pathogenesis of agents primarily affecting blood constituents is complex and involves the disruption of the balance of the blood components. this can be due to infections, toxins, or autoimmune reactions. the disruption of the balance of the blood components can lead to anemia, thrombocytopenia, leukopenia, or other abnormalities in the blood. these abnormalities can be further exacerbated by medications, environmental factors, or genetic predispositions.

Clinical Pattern

More details coming soon

How does a doctor diagnose

More details coming soon

Treatment and Medical Assistance

More details coming soon
Icon
17 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Agents primarily affecting blood constituents - Prevention

More details coming soon

Specified forms of the disease

(Y44.0) Iron preparations and other anti-hypochromic-anaemia preparations
(Y44.1) Vitamin B 12 , folic acid and other anti-megaloblastic-anaemia preparations
(Y44.2) Anticoagulants
(Y44.3) Anticoagulant antagonists, vitamin K and other coagulants
(Y44.4) Antithrombotic drugs [platelet-aggregation inhibitors]
(Y44.5) Thrombolytic drugs
(Y44.6) Natural blood and blood products
(Y44.7) Plasma substitutes
(Y44.9) Other and unspecified agents affecting blood constituents